The companion episode to the LEARNARAMA video “What You Need To Break Everything Wrong With The Internet.” Jonathan Murphy, PMHNP-BC, breaks down the structural argument of the video in real time, walking through the narrative from direct communication to the loop that keeps you scrolling. This episode covers the creative journey of making the video, the origins of the Learn-O-Rama series and the retro futurism of mid-century public education films, and why the channel looks and feels different from everything else in the ADHD space. The structural breakdown: direct communication has always produced a biological response, from a handwritten letter on the Pony Express to a DM on Bumble. Indirect communication has always shaped your fate, from Greek theater to the printing press to corporate broadcasting. But smartphones created the first two-way signal. Now every swipe, click, grimace, and maybe even vocalization produces a return signal aimed at maximizing the extraction of economic value from your attention. Search terms are the new supply and demand. YouTube is the new mainstream. And the mainstream is filled with anti-psychiatry physicians, wellness bros slinging supplements, Instagram influencers monetizing their medication experience, and TikTok docs thrust into the spotlight on a whim. Meanwhile corporate healthcare monoliths can hardly be bothered to make content. Nice try though. Educational content can be entertaining and informative. When the demand is met, the search terms reduce, and the flywheel slows down. That is the hope. That is Focus Path. The Process: An Adult’s Guide to ADHD Medication, available on Amazon Focus Path YouTube Channel: @FocusPathSystems X (Twitter): @ADHDAuthority

As the H3 Podcast goes on indefinite hiatus, psychiatric nurse practitioner Jonathan Murphy, PMHNP-BC, looks at the era of YouTube that H3H3 came to define. It started with short films and creative experiments like Angry Video Game Nerd and “Vape Nation” and became talking heads, podcasts, and parasocial engagement. He grew up alongside YouTube, and here he looks at what the platform rewards now, why licensed medical content gets labeled high risk, and what your attention is worth. This episode covers the difference between parasocial and prosocial relationships, why engagement-driven content keeps you watching without adding to your life, and how to judge what you get from the creators you follow. This episode covers:  ▸ Getting rid of the smartphone in 2019 and coming back online to teach  ▸ Growing up alongside YouTube  ▸ Why medication content gets flagged as high risk while unlicensed influencers don’t  ▸ Engagement versus education: what the algorithm rewards  ▸ Parasocial versus prosocial: why he answers questions one-on-one  ▸ Being a platform-native creator: clinical education made as short films  ▸ TikTok docs and the low barrier to entry  ▸ The podcast boom and the economics of AI slop  ▸ H3H3: from Vape Nation to the H3 Podcast’s collapse  ▸ Performed authority versus real authority  ▸ Internet culture as the new mainstream media  ▸ Parasocial communities, rejection sensitivity, and empty connection  ▸ Smartphones, passive engagement, and your brain  ▸ Your clicks and attention are worth more than you realize Find Jonathan on X @ADHDAuthority, or on YouTube at Focus Path Systems. 📕 The Process: An Adult’s Guide to ADHD Medication: https://www.amazon.com/dp/B0H2Z6PM4T 📗 Cheat Codes: https://www.amazon.com/dp/B0FMJLQKBW ⚠️ Educational purposes only. Not medical advice, and no clinical relationship is established by listening. Never start, stop, or change a medication without your prescriber. If you are in crisis, call or text 988. Jonathan Murphy, PMHNP-BC | Focus Path  Licensed in MA, NH, WA, OR | NPI 1821441965  Board Certified | ANCC 2017007119  CHADD Professional Member | ADDitude Professional Directory 🎥 https://www.youtube.com/@focuspathsystems 𝕏 @ADHDAuthority 🔗 https://myfocuspath.com 🔗 https://www.myfocuspath.blog 📧 https://mailchi.mp/myfocuspath/focus-path-pmhnp

The first edition of the Prescriber Toolkit. Psychiatric nurse practitioner Jonathan Murphy, PMHNP-BC, walks through methylphenidate the way he uses it in practice: where to start, how to judge a trial, when to raise the dose, and when to move to a different formulation. It opens with the bigger picture: the massive search demand for real-world ADHD medication information, the loop of grifters, pseudoscience, and engagement algorithms that fills it, and why receptor-level debates can lose the plot. Then the toolkit: Ritalin LA, Concerta, Metadate CD, Jornay PM, Focalin, Aptensio, and Azstarys, plus alcohol and methylphenidate. This episode covers:  ▸ Holding the frame: real-world impact on the patient  ▸ Unmet demand: why “what do I do on my first day of Vyvanse?” goes unanswered  ▸ The loop: grifters, wellness pseudoscience, Reddit, and engagement algorithms  ▸ The SimCity analogy: psychopharmacology without losing the forest for the trees  ▸ Neurons, synapses, and dopamine “buttons,” in plain language  ▸ Methylphenidate versus amphetamine: why methylphenidate is less stimulating  ▸ Who might start on methylphenidate: anxiety, autism, or overstimulation on amphetamines  ▸ Ritalin LA 20 mg or Concerta 36 mg as a starting point, and how Concerta’s tablet differs  ▸ Metadate CD for longer duration, and dosing up to 60 mg  ▸ When to increase the dose: duration, tiredness, partial response  ▸ Why the first week isn’t the test: give a trial a month  ▸ Jornay PM: the nighttime dose, and why the milligrams don’t compare directly  ▸ Focalin (dexmethylphenidate): when it’s the one that finally works  ▸ Aptensio and Azstarys: why the ratios don’t matter much and availability does  ▸ Alcohol and methylphenidate: why to avoid the combination  ▸ How ADHD medication can curb the stimulation-seeking behind substance use New on YouTube: the Rx Info installment on Vyvanse. Search @FocusPathSystems. Questions: X @ADHDAuthority. 📕 The Process: An Adult’s Guide to ADHD Medication: https://www.amazon.com/dp/B0H2Z6PM4T 📗 Cheat Codes: https://www.amazon.com/dp/B0FMJLQKBW ⚠️ Educational purposes only. Not medical advice, and no clinical relationship is established by listening. Never start, stop, or change a medication without your prescriber. If you are in crisis, call or text 988. Jonathan Murphy, PMHNP-BC | Focus Path  Licensed in MA, NH, WA, OR | NPI 1821441965  Board Certified | ANCC 2017007119  CHADD Professional Member | ADDitude Professional Directory 🎥 https://www.youtube.com/@focuspathsystems 𝕏 @ADHDAuthority 🔗 https://myfocuspath.com 🔗 https://www.myfocuspath.blog 📧 https://mailchi.mp/myfocuspath/focus-path-pmhnp

Actually ADHD is ranked #1 on Apple Podcasts and Spotify for ADHD medication. In this episode, Jonathan Murphy, PMHNP-BC, tells the story behind the perspective: crashing out at 22, taking a job for the health insurance, and working his way from counselor on an adult inpatient psych unit at Pembroke Hospital to nurse on the child and adolescent psychiatry unit at Boston Children’s Hospital, then to psychiatric mental health nurse practitioner at an ADHD clinic. He explains why he left inpatient psychiatry and pediatrics to treat adults only, how a psychiatric nurse practitioner’s training shapes the way he talks about ADHD medication, and why he doesn’t present himself as the authority figure common on physician-led podcasts. Having taken ADHD medication himself through adolescence and adulthood, he describes learning that ADHD medication treatment is less about the drug and more about the individual: the right medication, for the right person, for the right reason. The episode also introduces Rx Info, his YouTube series of in-depth medication reviews covering manufacturing, FDA regulation, track record and clinical use, with a new episode on Vyvanse (lisdexamfetamine). It previews the Prescriber’s Toolkit, an upcoming podcast series for patients and clinicians on how ADHD medications like methylphenidate are used in real practice. Educational content only. This podcast does not provide medical advice. Talk with your own prescriber before starting, stopping or changing any medication. YouTube: @FocusPathSystems | X: @ADHDAuthority

Rejection sensitive dysphoria (RSD) has become one of the most viral labels attached to ADHD online. Psychiatric nurse practitioner Jonathan Murphy, PMHNP-BC, explains why RSD is not a psychiatric diagnosis, why it matters for anyone trying to get effective ADHD treatment, and what happens when internet labels follow patients into the exam room. This episode argues that rejection sensitivity is a human experience, not an ADHD symptom, and looks at how a viral label can steer treatment toward guanfacine and away from first-line extended-release stimulants. It covers media literacy, the silent majority, and why your goal is your own life, not a tribe. This episode covers:  ▸ Why mental health is being politicized, and why that matters  ▸ RSD as a viral label, not a DSM diagnosis  ▸ Russell Barkley on rejection sensitivity and ADHD  ▸ Correlation isn't causation: why the most universal experiences go the most viral  ▸ Why psychiatric diagnoses should never be decided by popularity  ▸ The diagnostic soup: labels as tools, not identities  ▸ Guanfacine, alpha-2 agonists, and RSD  ▸ Why extended-release stimulants remain first-line ADHD treatment  ▸ How RSD can create friction with your treatment provider  ▸ The pseudo-environment versus the real world  ▸ Rejection as a stress response, and learning emotional self-regulation  ▸ ADHD, technology dependence, and the algorithm  ▸ No sponsors, no supplements, no tip jar: why that matters  ▸ Media literacy: setting and defining your own terms Find Jonathan on X @ADHDAuthority, or on YouTube at Focus Path Systems. 📕 The Process: An Adult's Guide to ADHD Medication: https://www.amazon.com/dp/B0H2Z6PM4T 📗 Cheat Codes: https://www.amazon.com/dp/B0FMJLQKBW ⚠️ Educational purposes only. Not medical advice, and no clinical relationship is established by listening. Never start, stop, or change a medication without your prescriber. If you are in crisis, call or text 988. Jonathan Murphy, PMHNP-BC | Focus Path  Licensed in MA, NH, WA, OR | NPI 1821441965  Board Certified | ANCC 2017007119  CHADD Professional Member | ADDitude Professional Directory 🎥 https://www.youtube.com/@focuspathsystems 𝕏 @ADHDAuthority 🔗 https://myfocuspath.com 🔗 https://www.myfocuspath.blog 📧 https://mailchi.mp/myfocuspath/focus-path-pmhnp